摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-(+)-2-(2-Methoxyphenyl)-1-propanol | 96641-45-1

中文名称
——
中文别名
——
英文名称
(S)-(+)-2-(2-Methoxyphenyl)-1-propanol
英文别名
(2S)-2-(2-methoxyphenyl)propan-1-ol;2-(2-methoxyphenyl)propan-1-ol;(S)-2-methoxy-β-methylbenzeneethanol
(S)-(+)-2-(2-Methoxyphenyl)-1-propanol化学式
CAS
96641-45-1
化学式
C10H14O2
mdl
——
分子量
166.22
InChiKey
TWPWTDPROGCEAS-MRVPVSSYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    95 °C(Press: 1.2 Torr)
  • 密度:
    1.032±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S)-(+)-2-(2-Methoxyphenyl)-1-propanol咪唑 、 sodium hydride 、 三苯基膦 作用下, 以 乙醚N,N-二甲基甲酰胺乙腈 、 mineral oil 为溶剂, 反应 17.75h, 生成
    参考文献:
    名称:
    一种简单的2-芳基乙醛的有机催化烷基化:一种双双硼烷的方法。
    摘要:
    AbstractA highly stereoselective organocatalytic α‐alkylation of 2‐arylacetaldehydes with a commercially available carbenium tetrafluoroborate is described. The stereoselective alkylation was carried out in acetonitrile/water, under air in the presence of a commercially available imidazolidinone (MacMillan’s catalyst). Key intermediates for the synthesis of bisabolanes were obtained through a simple chemistry. In particular a direct, enantioselective and facile synthesis of (R)‐(−)‐curcumene is described.magnified image
    DOI:
    10.1002/adsc.201300250
  • 作为产物:
    描述:
    2-烯丙基苯甲醚 在 sodium tetrahydroborate 、 氢气臭氧(5S)-(-)-2,2,3-trimethyl-5-benzyl-4-imidazolidinone monohydrochloride 作用下, 以 甲醇乙醇二氯甲烷乙腈 为溶剂, -78.0~20.0 ℃ 、101.33 kPa 条件下, 反应 39.67h, 生成 (S)-(+)-2-(2-Methoxyphenyl)-1-propanol
    参考文献:
    名称:
    一种简单的2-芳基乙醛的有机催化烷基化:一种双双硼烷的方法。
    摘要:
    AbstractA highly stereoselective organocatalytic α‐alkylation of 2‐arylacetaldehydes with a commercially available carbenium tetrafluoroborate is described. The stereoselective alkylation was carried out in acetonitrile/water, under air in the presence of a commercially available imidazolidinone (MacMillan’s catalyst). Key intermediates for the synthesis of bisabolanes were obtained through a simple chemistry. In particular a direct, enantioselective and facile synthesis of (R)‐(−)‐curcumene is described.magnified image
    DOI:
    10.1002/adsc.201300250
点击查看最新优质反应信息

文献信息

  • DNA-PK INHIBITORS
    申请人:Vertex Pharmaceuticals Incorporated
    公开号:US20130281431A1
    公开(公告)日:2013-10-24
    The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
    本发明涉及作为DNA-PK抑制剂的化合物。该发明还提供了包含所述化合物的药物可接受的组合物,以及使用所述组合物治疗各种疾病、状况或失调的方法。
  • On the Stereochemical Course of Palladium-Catalyzed Cross-Coupling of Allylic Silanolate Salts with Aromatic Bromides
    作者:Scott E. Denmark、Nathan S. Werner
    DOI:10.1021/ja910804u
    日期:2010.3.17
    palladium-catalyzed cross-coupling reactions of an enantioenriched, alpha-substituted, allylic silanolate salt with aromatic bromides has been investigated. The allylic silanolate salt was prepared in high geometrical (Z/E, 94:6) and high enantiomeric (94:6 er) purity by a copper-catalyzed S(N)2' reaction of a resolved allylic carbamate. Eight different aromatic bromides underwent cross-coupling with excellent
    已经研究了钯催化的对映体富集的、α 取代的烯丙基硅烷醇盐与芳族溴化物的交叉偶联反应的立体化学过程。通过铜催化的 S(N)2' 反应分解的烯丙基氨基甲酸酯,以高几何 (Z/E,94:6) 和高对映体 (94:6 er) 纯度制备烯丙基硅烷醇盐。八种不同的芳香族溴化物以优异的结构位点选择性和立体特异性进行交叉偶联。立体化学相关性确定金属转移事件通过 Syn S(E)' 机制进行,该机制解释为芳基钯亲电试剂通过包含离散 Si-O-Pd 键的关键中间体的分子内传递。
  • Enantioselective Synthesis of 4-Methyl-3,4-dihydroisocoumarin via Asymmetric Hydroformylation of Styrene Derivatives
    作者:Bo Qu、Renchang Tan、Madison R. Herling、Nizar Haddad、Nelu Grinberg、Marisa C. Kozlowski、Xumu Zhang、Chris H. Senanayake
    DOI:10.1021/acs.joc.8b02813
    日期:2019.4.19
    Enantioenriched aldehydes are produced through asymmetric hydroformylation of styrene derivatives using BIBOP-type ligands. The featured example is enantioselective synthesis of 4-methyl-3,4-dihydroisocoumarin, which was prepared in a 95.1:4.9 enantiomeric ratio from asymmetric hydroformylation of ethyl 2-vinylbenzoate followed by in situ lactonization during the reduction process. The conditions are
    使用BIBOP型配体通过苯乙烯衍生物的不对称加氢甲酰化制得对映体丰富的醛。典型的例子是4-甲基-3,4-二氢异香豆素的对映选择性合成,该合成是通过2-乙烯基苯甲酸乙酯的不对称加氢甲酰化,然后在还原过程中进行原位内酯化而以95.1:4.9的对映体比例制备的。该条件与富电子和贫电子的取代基均相容。
  • The Total Synthesis of (15<i>R</i>)- and (15<i>S</i>)-16-Hydroxyferruginol
    作者:Takashi Matsumoto、Sachihiko Imai、Shigekazu Miuchi、Hidenori Sugibayashi
    DOI:10.1246/bcsj.58.340
    日期:1985.1
    um chloride (3a) and its (S)-isomer (3b) respectively. The Wittig reaction of (R)-(−)-α-cyclocitral with 3a, followed by partial catalytic hydrogenation and intramolecular cyclization gave (5S,10S, 15S)-12,16-dimethoxy-8,11,13-abietatriene (16a) together with its (5S,10R,15R)-isomer. Similarly, 3b was also converted into (5S,10S,15S)-12,16-dimethoxy-8,11,13-abietatriene (16b) and its (5S,10R,15S)-isomer
    为了确定天然 16-羟基铁杉醇中 C-15 的绝对构型,(5S,10S,15R)- (1a) 和 (5S,10S,15S)-8,11,13-abietatriene-12,16-diol (1b) 已合成。由(2-甲氧基苯基)乙酸甲酯制备的 2-(2-甲氧基苯基)丙酸与辛可尼丁进行光学拆分,得到 (R)- 和 (S)- 对映异构体,将其转化为 [(R)-4-甲氧基- 3-(2-甲氧基-1-甲基乙基)苄基]三苯基氯化鏻(3a)及其(S)-异构体(3b)。(R)-(-)-α-环柠檬醛与 3a 的 Wittig 反应,然后部分催化加氢和分子内环化得到 (5S,10S, 15S)-12,16-二甲氧基-8,11,13-松香三烯 (16a ) 及其 (5S,10R,15R)-异构体。类似地,3b也被转化为(5S,10S,15S)-12,16-二甲氧基-8,11,13-松香三烯(16b)及其(5S,10R
  • DNA-PK inhibitors
    申请人:Vertex Pharmaceuticals Incorporated
    公开号:US09376448B2
    公开(公告)日:2016-06-28
    The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
    本发明涉及用作DNA-PK抑制剂的化合物。本发明还提供了包含所述化合物的药学上可接受的组合物以及使用该组合物治疗各种疾病、病况或障碍的方法。
查看更多